Literature DB >> 9852445

Viridans streptococcal bacteremia after esophageal stricture dilation.

G Zuccaro1, J E Richter, T W Rice, E Achkar, K Easley, J Lewis, S M Gordon.   

Abstract

BACKGROUND: The incidence of bacteremia with organisms that may cause infective endocarditis after esophageal stricture dilation is unknown. There is disagreement among physicians regarding the need for antibiotic prophylaxis for patients with valvular heart disease undergoing dilation. Our aim was to determine the frequency and duration of bacteremia associated with esophageal stricture dilation.
METHODS: Blood cultures were obtained before and after stricture dilation in patients without valvular heart disease and in a control group of patients undergoing upper endoscopy without dilation.
RESULTS: A total of 103 patients undergoing dilation and 50 control patients were studied; 22 of 103 patients (21%) undergoing dilation had at least one post-procedure blood culture positive for viridans streptococcus, compared with 1 of 50 (2%) of control patients (p = 0. 001). Blood cultures obtained 1 minute after stricture dilation were positive for viridans streptococcus in 19 of 81 (23%), in 16 of 96 (17%) 5 minutes post-dilation, and in 3 of 63 (5%) 20 to 30 minutes post-dilation. Of the 19 patients with viridans streptococcus bacteremia 1 minute after dilation, cultures were still positive in 14 of 19 (74%) at 5 minutes and in 2 of 19 (10%) 20 to 30 minutes post-dilation.
CONCLUSIONS: These data support the use of antibiotic prophylaxis before esophageal stricture dilation for patients with valvular heart disease at risk for the development of infective endocarditis.

Entities:  

Mesh:

Year:  1998        PMID: 9852445     DOI: 10.1016/s0016-5107(98)70037-9

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

1.  Frequent occurrence of fever in patients who have undergone endoscopic submucosal dissection for colorectal tumor, but bacteremia is not a significant cause.

Authors:  Kentaro Izumi; Taro Osada; Naoto Sakamoto; Tomohiro Kodani; Yoshie Higashihara; Hideaki Ritsuno; Tomoyoshi Shibuya; Akihito Nagahara; Tatsuo Ogihara; Ken Kikuchi; Sumio Watanabe
Journal:  Surg Endosc       Date:  2014-05-23       Impact factor: 4.584

2.  A rare complication of esophageal dilatation: Brain abscess.

Authors:  Nagehan Aslan; Esra Sesli; Tuba Koca; Nilgün Şenol; Mustafa Akçam
Journal:  Turk Pediatri Ars       Date:  2017-03-01

Review 3.  Endoscopic Management of Refractory Benign Esophageal Strictures.

Authors:  Alessandro Fugazza; Alessandro Repici
Journal:  Dysphagia       Date:  2021-03-12       Impact factor: 3.438

Review 4.  Preventing nosocomial infections from gastrointestinal endoscopy.

Authors:  D Franchi; A Bahrani; J F Ober; M B Edmond
Journal:  Curr Gastroenterol Rep       Date:  2000-08

5.  Staphylococcus lugdunensis Infectious Endocarditis Complicated by Embolic Stroke After Colonoscopy in a 58-Year-Old Female.

Authors:  Rafsan Ahmed; Mahmoud Alsaiqali; Asher Gorantla; Shruthi Sivakumar; Michelle Feinberg; Suzette Graham-Hill; Louis Salciccioli
Journal:  Cureus       Date:  2022-04-28

Review 6.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

7.  Dilation of malignant strictures in endoscopic ultrasound staging of esophageal cancer and metastatic spread of disease.

Authors:  Shawn M Hancock; Deepak V Gopal; Terrence J Frick; Patrick R Pfau
Journal:  Diagn Ther Endosc       Date:  2011-11-30

8.  Clinical impact of prophylactic antibiotic treatment for self-expandable metallic stent insertion in patients with malignant colorectal obstruction.

Authors:  Jong-Sun Kim; Wan-Sik Lee; Cho-Yun Chung; Hyung-Chul Park; Dae-Seong Myung; Chan-Young Oak; Mi-Young Kim; Mi-Ok Jang; Seung-Ji Kang; Hee-Chang Jang; Sung-Bum Cho; Hyun-Soo Kim; Young-Eun Joo
Journal:  Gastroenterol Res Pract       Date:  2015-03-31       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.